Imprimis NJOF, LLC: Drug Recall

Recall #D-0040-2024 · 10/03/2023

Class III: Low Risk

Recall Details

Recall Number
D-0040-2024
Classification
Class III
Product Type
Drug
Recalling Firm
Imprimis NJOF, LLC
Status
Terminated
Date Initiated
10/03/2023
Location
Ledgewood, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
364 bags (1 mL filled in 2 mL glass amber vials; 20 vials shipped in a bag)

Reason for Recall

Subpotent: Failing Test Results for Epinephrine

Product Description

Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01 Not for resale. Office use only. Lot: 23APR018 Date Compounded: 24APR2023 Expires on: 17APR2024. In case of adverse event contact: www.fda.gov/medwatch or (800)-FDA-1088 Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852 (844) 446-6979

Distribution Pattern

Nationwide

Other Recalls by Imprimis NJOF, LLC

View all recalls by Imprimis NJOF, LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.